Metformin Hydrochloride Powder CAS 1115-70-4 Raw Material

CAS: 1115-70-4

MF: C4H12ClN5

MW: 165.62

EINECS: 214-230-6

Specification​: 99% min Metformin Hydrochloride

Sample: Metformin Hydrochloride Powder

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Portal:https://henrikang.en.made-in-china.com/

Metformin Hydrochloride Powder Usage and Synthesis.

Metformin Hydrochloride is a biguanide oral hypoglycemic agent, Metformin Hydrochloride Powder, also known as Metformin Hydrochloride, Gevalt. Medecan, has a weaker hypoglycemic effect than benzidine, Metformin Hydrochloride Raw Materials main action is to reduce The main effect of Metformin Hydrochloride Raw Material is to reduce the secretion of A-cell glucagon and promote the conversion of glucose into glycogen. Metformin Hydrochloride has the property of not stimulating insulin secretion by pancreatic beta-cells.

Metformin Hydrochloride Powder is a white crystalline or crystalline powder. Melting point 232°C (218-220°C). Soluble in water, soluble in methanol, slightly soluble in ethanol, insoluble in ether and chloroform. Odourless, bitter taste.

Uses and functions of Metformin Hydrochloride Powder.

Metformin Hydrochloride is mainly used for the treatment of type II diabetes mellitus in patients with unsatisfactory dietary control alone, especially in obese and hyperinsulinemic patients, where it may have not only hypoglycaemic but also weight loss and hyperinsulinemic effects.

It may be effective in some patients with poor efficacy of sulphonylureas, for example, in combination with sulphonylureas, small intestine glucosidase inhibitors or thiazolidinediones to lower blood glucose, which is more effective than using them separately.

It can also be used in patients on insulin therapy to reduce insulin dosage. Metformin hydrochloride is an anti-diabetic agent that reduces blood glucose levels and improves insulin sensitivity. Its metabolism (including inhibition of hepatic glycogen isogenesis) is activated via the LKB1-AMPK (AMP-activated protein kinase) pathway.

This product is a hypoglycaemic agent. It reduces fasting and postprandial hyperglycaemia and HbAlc by 1% to 2% in patients with type II diabetes.

The mechanism by which this product lowers blood glucose may be:

1. Increase the sensitivity of peripheral tissues to insulin and increase insulin-mediated glucose utilization.
2. Increase glucose utilization by non-insulin-dependent tissues, such as brain, blood cells, renal medulla, intestine, skin, etc.
3. Inhibits hepatic glycogen allogeneesis and reduces hepatic glucose output.
4. Inhibits glucose uptake by intestinal wall cells.

Pharmacological Effects of Metformin Hydrochloride Powder.

The mechanism of hypoglycaemic action of Metformin Hydrochloride is as follows:

• 1. Increases insulin sensitivity of peripheral tissues and increases insulin-mediated glucose utilization.
• 2. Increase glucose utilization in non-insulin-dependent tissues, such as brain, blood cells, renal medulla, intestine, skin, etc.
• 3. Inhibits hepatic glycogen allogenesis and reduces hepatic glucose output.
• 4. Inhibits glucose uptake by intestinal wall cells.
• 5. Inhibits the biosynthesis and storage of cholesterol and reduces blood triglyceride and total cholesterol levels.

Production method of Metformin Hydrochloride Powder.

Metformin Hydrochloride Powder is produced by the reaction of dimethylamine with dicyandiamide as a salt.